Biosimilars

COVID-19

Cataract

Cataract Therapeutics

Clinical Diagnosis

Cornea

Dry Eye

Gene Therapy

Glaucoma

Imaging

Obstetrics-Gynecology & Women's Health

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Presbyopia

Ptosis

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Urology

News

All News

Contributors

Money Matters

Media

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Insights

Viewpoints

Conferences

Conference Coverage

Conference Listing

Conference Recaps

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Print Subscription

eNewsletter

Resources

Job Board

Advertise

Privacy

Editorial

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Twitter

Instagram

LinkedIn

Spotlight

Presbyopia: A part of Aging and Challenges

Clinical

1rem

Optical coherence tomography angiography is finding new uses in glaucoma, as it can depict loss of blood vessels around the optic nerve and distinguish vascular layers.

Angiography boosts OCT in glaucoma

Investigators show the effectiveness of Home-OCT based remote monitoring model. 

Efficacy of Notal Vision OCT device demonstrated by a series of scientific and clinical work

A partnership that includes BALANCED Media|Technology, the Retina Foundation of the Southwest and Southern Methodist University is seeking a patent for machine learning software for OCT images aids in identity progression and treatment options

Partnership develops video game software patented for age-related macular degeneration research

Investigators hoping to develop a novel artificial intelligence model.

Study targets use of swept-source OCT to measure macular hole volume

Proposal hints at the use of generative adversarial network (GAN) for applications in macular surgery

Postoperative prediction of OCT using conditional generative adversarial network 

Retinal and choroidal changes were observed in study.

OCT/OCTA ocular biomarkers may help diagnose Parkinson disease

Justis P. Ehlers, MD, The Norman C. and Donna L. Harbert Endowed Chair for Ophthalmic Research, Cole Eye Institute, Cleveland, Ohio, speaks with 

 Sheryl Stevenson on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study. 

Are there predictive factors that clinicians can identify in patients who may be more at risk for developing inflammation so that they can mitigate risk? 

Learn what this research may mean for clinicians and their patients.



Videos

Justis P. Ehlers, MD, speaks on the findings from a higher-order OCT analysis for inflammatory signal biomarkers in the HAWK Study.

HAWK study: Higher order OCT analysis for inflammatory signal biomarkers

Tibor Juhasz, CEO of ViaLase, Inc, discusses the company's development of a novel, noninvasive high-resolution OCT image-guided femtosecond laser technology for the treatment of open-angle glaucoma.

ViaLase CEO talks innovations in glaucoma treatment

Daniel F. Kiernan, MD, a vitreoretinal surgeon at The Eye Associates, Sarasota, Florida, discusses the highlights of his 2021 ARVO virtual presentation on the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on optical coherence tomography (OCT) testing following vitreoretinal surgery.

Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.

Clinical results study dexamethasone implant effect on macular thickness

Justis P. Ehlers, MD, of the Cole Eye Institute at the Cleveland Clinic, speaks with 

' David Hutton on the key findings and take-aways from his presentation "Impact of baseline OCT characteristics on response to risuteganib for the treatment of intermediate age-related macular degeneration (AMD)" during the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

Justis P. Ehlers, MD, speaks on the key findings and take-aways from his presentation "Impact of baseline OCT characteristics on response to risuteganib for the treatment of intermediate age-related macular degeneration (AMD)."

Impact of baseline OCT on response to risuteganib for treatment of intermediate AMD (ASRS 2020)

 David Hutton on the highlights of his presentation "OCT angiography vs laser speckle contrast imaging," where he analyzes the correlation of static and dynamic measurements of peripapillary blood flow in glaucoma, glaucoma suspect, and healthy eyes, during the 2020 virtual ARVO meeting.


ARVO 2020: OCT-A vs laser speckle contrast imaging

OCT

More News